Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A FitzGerald

Showing results (31-40 of 310) with videos related to

Pageof 31
Sort By:
European Heart Journal|December 1, 1993
Cellular activation by thromboxane A2 and other eicosanoidsM Reilly, G A Fitzgerald
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humansJ Nowak, G A FitzGerald
The American Journal of Clinical Nutrition|May 1, 1997
Dietary factors in thrombosis and hemostasis: summary and conclusionsG A FitzGerald, P Barry
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|February 13, 2002
Oxidant stress in cardiovascular disease: an emerging modality or a disproved theory?C Patrono, G A FitzGerald
The Journal of Clinical Investigation|February 1, 1989
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in manJ Nowak, G A FitzGerald
The American Journal of Physiology|July 1, 1988
Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humansA Wennmalm, G A Fitzgerald
Thrombosis Research|September 15, 1987
Paired analysis of urinary thromboxane B2 metabolites in humansF Catella, G A FitzGerald
Thrombosis and Haemostasis|December 22, 1999
Mechanisms of cellular activation by platelet microparticlesO P Barry, G A FitzGerald
Clinical Pharmacology and Therapeutics|May 1, 1984
Selective and nonselective inhibition of thromboxane formationG A FitzGerald, J A Oates
Blood|January 1, 1987
Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugsI A Reilly, G A FitzGerald
Pageof 31

Showing results (31-40 of 310) with videos related to

Sort By:
Pageof 31
European Heart Journal|December 1, 1993
Cellular activation by thromboxane A2 and other eicosanoidsM Reilly, G A Fitzgerald
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humansJ Nowak, G A FitzGerald
The American Journal of Clinical Nutrition|May 1, 1997
Dietary factors in thrombosis and hemostasis: summary and conclusionsG A FitzGerald, P Barry
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|February 13, 2002
Oxidant stress in cardiovascular disease: an emerging modality or a disproved theory?C Patrono, G A FitzGerald
The Journal of Clinical Investigation|February 1, 1989
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in manJ Nowak, G A FitzGerald
The American Journal of Physiology|July 1, 1988
Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humansA Wennmalm, G A Fitzgerald
Thrombosis Research|September 15, 1987
Paired analysis of urinary thromboxane B2 metabolites in humansF Catella, G A FitzGerald
Thrombosis and Haemostasis|December 22, 1999
Mechanisms of cellular activation by platelet microparticlesO P Barry, G A FitzGerald
Clinical Pharmacology and Therapeutics|May 1, 1984
Selective and nonselective inhibition of thromboxane formationG A FitzGerald, J A Oates
Blood|January 1, 1987
Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugsI A Reilly, G A FitzGerald
Pageof 31